Business · 27/05/2021
FDA Issues Emergency Use Authorizations for COVID-19 Biological Products
The US Food and Drug Administration (FDA) has granted two Emergency Use Authorizations (EUAs) for biological products to combat COVID-19, following a public health emergency declaration by the Secretary of Health and Human Services in February 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →
Related company profile: Eli Lilly and CompanyOpen profile →Explore businesses on Business Maps →